Spinal Cord Stimulators (SCS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

SCS Pipeline Products Market Overview

An SCS is a device that comprises a surgically-implanted electrical pacemaker and electrodes that connect to the spinal cord to treat chronic pain disorders. The SCS pipeline market research report provides comprehensive information about the SCS pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Territories ·       The US

·       Europe

·       China

·       Australia

·       Canada

Key Regulatory Paths ·       PMA

·       510(k)

·       CE

·       NMPA

·       TGA

·       UKCA

·       De Novo

Leading Companies ·       Beijing Leading Medical Valley Technology Development Co Ltd

·       Beijing Lingchuang Yigu Technology Development Co Ltd

·       Boston Scientific Corp

·       Cerevast Therapeutics Inc

·       Direct Spinal Therapeutics, Inc.

·       Duke University

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

SCS Pipeline Market Segmentation by Territories

Some of the key territories in the SCS market are the US, Europe, China, Australia, and Canada among others. As of May 2023, the US has the highest number of pipeline products.

SCS Pipeline Market Analysis, by Territories, 2023 (%)

SCS Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the SCS pipeline market, download a free report sample

SCS Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the SCS pipeline market are PMA, 510(k), CE, NMPA, TGA, UKCA, and De Novo among others. As of May 2023, PMA is the most followed pathway for pipeline products.

SCS Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

SCS Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the SCS pipeline market, download a free report sample

SCS Pipeline Market – Competitive Landscape

Some of the key companies in the SCS pipeline market are Beijing Leading Medical Valley Technology Development Co Ltd, Beijing Lingchuang Yigu Technology Development Co Ltd, Boston Scientific Corp, Cerevast Therapeutics Inc, Direct Spinal Therapeutics, Inc., and Duke University among others.

Beijing Leading Medical Valley Technology Development Co Ltd: Beijing Leading Medical Valley Technology Development Co Ltd (Medical Valley Technology) is a medical device company that is engaged in developing technologies for implantable neuroelectric stimulation to treat neurological functioning disorders. Medical Valley Technology is headquartered in Beijing, China.

Segments Covered in the Report

SCS Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Australia
  • Canada

SCS Pipeline Market Regulatory Paths Outlook

  • PMA
  • 510(k)
  • CE
  • NMPA
  • TGA
  • UKCA
  • De Novo

Scope

  • Extensive coverage of the SCS under development
  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities
  • Reviews the major players involved in the development of SCS and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of SCS under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

Beijing Leading Medical Valley Technology Development Co Ltd
Beijing Lingchuang Yigu Technology Development Co Ltd
Boston Scientific Corp
Cerevast Therapeutics Inc
Direct Spinal Therapeutics, Inc.
Duke University
Hangzhou Shenluo Medical Technology Co Ltd
Imperial College London
Lawson Health Research Institute
Meagan Medical Inc.
Medtronic Inc
Medtronic Plc
Micro-Leads Inc
MicroTransponder Inc
Neuronoff Inc
NeuroOne Medical Technologies Corp
Nevro Corp
Nexstim Plc
Nuvectra Corp (Inactive)
Onward Medical NV
Onward Technologies Ltd
Quantum Nanostim LLC
Reach Neuro Inc
Rowan University
Saluda Medical Pty Ltd
Soin Neuroscience Inc
Soterix Medical Inc
SpineX
Sree Chitra Tirunal Institute for Medical Sciences & Technology
St. Jude Medical LLC
Stimdia Medical Inc
SynerFuse Inc
University of California Los Angeles
University of Cambridge
University of Minnesota
Wavegate Corp
WISE s.r.l.

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables
    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Spinal Cord Stimulators (SCS) Overview

  • 3 Products under Development

    • 3.1 Spinal Cord Stimulators (SCS) – Pipeline Products by Stage of Development
    • 3.2 Spinal Cord Stimulators (SCS) – Pipeline Products by Territory
    • 3.3 Spinal Cord Stimulators (SCS) – Pipeline Products by Regulatory Path
    • 3.4 Spinal Cord Stimulators (SCS) – Pipeline Products by Estimated Approval Date
    • 3.5 Spinal Cord Stimulators (SCS) – Ongoing Clinical Trials

  • 4 Spinal Cord Stimulators (SCS) – Pipeline Products under Development by Companies

    • 4.1 Spinal Cord Stimulators (SCS) Companies – Pipeline Products by Stage of Development
    • 4.2 Spinal Cord Stimulators (SCS) – Pipeline Products by Stage of Development

  • 5 Spinal Cord Stimulators (SCS) Companies and Product Overview

    • 5.1 Beijing Leading Medical Valley Technology Development Co Ltd Company Overview

      • 5.1.1 Beijing Leading Medical Valley Technology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Beijing Lingchuang Yigu Technology Development Co Ltd Company Overview

      • 5.2.1 Beijing Lingchuang Yigu Technology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Boston Scientific Corp Company Overview

      • 5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 Cerevast Therapeutics Inc Company Overview

      • 5.4.1 Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 Direct Spinal Therapeutics, Inc. Company Overview

      • 5.5.1 Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Duke University Company Overview

      • 5.6.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 Hangzhou Shenluo Medical Technology Co Ltd Company Overview

      • 5.7.1 Hangzhou Shenluo Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 Imperial College London Company Overview

      • 5.8.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Lawson Health Research Institute Company Overview

      • 5.9.1 Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Meagan Medical Inc. Company Overview

      • 5.10.1 Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Medtronic Inc Company Overview

      • 5.11.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Medtronic Plc Company Overview

      • 5.12.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Micro-Leads Inc Company Overview

      • 5.13.1 Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 MicroTransponder Inc Company Overview

      • 5.14.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 Neuronoff Inc Company Overview

      • 5.15.1 Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 NeuroOne Medical Technologies Corp Company Overview

      • 5.16.1 NeuroOne Medical Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 Nevro Corp Company Overview

      • 5.17.1 Nevro Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Nexstim Plc Company Overview

      • 5.18.1 Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 Nuvectra Corp (Inactive) Company Overview

      • 5.19.1 Nuvectra Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 Onward Medical NV Company Overview

      • 5.20.1 Onward Medical NV Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 Onward Technologies Ltd Company Overview

      • 5.21.1 Onward Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 Quantum Nanostim LLC Company Overview

      • 5.22.1 Quantum Nanostim LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23 Reach Neuro Inc Company Overview

      • 5.23.1 Reach Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.24 Rowan University Company Overview

      • 5.24.1 Rowan University Pipeline Products & Ongoing Clinical Trials Overview

    • 5.25 Saluda Medical Pty Ltd Company Overview

      • 5.25.1 Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.26 Soin Neuroscience Inc Company Overview

      • 5.26.1 Soin Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.27 Soterix Medical Inc Company Overview

      • 5.27.1 Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.28 SpineX Company Overview

      • 5.28.1 SpineX Pipeline Products & Ongoing Clinical Trials Overview

    • 5.29 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview

      • 5.29.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview

    • 5.30 St. Jude Medical LLC Company Overview

      • 5.30.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.31 Stimdia Medical Inc Company Overview

      • 5.31.1 Stimdia Medical Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.32 SynerFuse Inc Company Overview

      • 5.32.1 SynerFuse Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.33 University of California Los Angeles Company Overview

      • 5.33.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

    • 5.34 University of Cambridge Company Overview

      • 5.34.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview

    • 5.35 University of Minnesota Company Overview

      • 5.35.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview

    • 5.36 Wavegate Corp Company Overview

      • 5.36.1 Wavegate Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.37 WISE s.r.l. Company Overview

      • 5.37.1 WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Spinal Cord Stimulators (SCS)- Recent Developments
  • 7 Appendix

    • 7.1 Methodology
    • 7.2 About GlobalData
    • 7.3 Contact Us
    • 7.4 Disclaimer

Table

Spinal Cord Stimulators (SCS) – Pipeline Products by Stage of Development 13

Spinal Cord Stimulators (SCS) – Pipeline Products by Territory 14

Spinal Cord Stimulators (SCS) – Pipeline Products by Regulatory Path 15

Spinal Cord Stimulators (SCS) – Pipeline Products by Estimated Approval Date 16

Spinal Cord Stimulators (SCS) – Ongoing Clinical Trials 17

Spinal Cord Stimulators (SCS) Companies – Pipeline Products by Stage of Development 18

Spinal Cord Stimulators (SCS) – Pipeline Products by Stage of Development 20

Beijing Leading Medical Valley Technology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

Spinal Cord Nerve Stimulation Device – Product Status 22

Spinal Cord Nerve Stimulation Device – Product Description 22

Beijing Lingchuang Yigu Technology Development Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 23

Neural Electrical Stimulation Device – Pain – Product Status 23

Neural Electrical Stimulation Device – Pain – Product Description 23

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 24

Next Generation SCS System – Product Status 24

Next Generation SCS System – Product Description 24

WaveWriter Spinal Cord Stimulator (SCS) System – Non-Surgical Back Pain – Product Status 25

WaveWriter Spinal Cord Stimulator (SCS) System – Non-Surgical Back Pain – Product Description 25

Boston Scientific Corp – Ongoing Clinical Trials Overview 26

WaveWriter Spinal Cord Stimulator (SCS) System – Non-Surgical Back Pain – A Randomized Controlled Study to Evaluate the Safety and Effectiveness of Boston Scientific Spinal Cord Stimulation (SCS) Systems in the Treatment of Chronic Low Back and/or Leg Pain with No Prior Surgeries 27

Cerevast Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 28

Transdermal Electrical Neurostimulation Device – Product Status 28

Transdermal Electrical Neurostimulation Device – Product Description 28

Direct Spinal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29

Iowa-Patch System – Product Status 29

Iowa-Patch System – Product Description 29

Duke University Pipeline Products & Ongoing Clinical Trials Overview 30

Spinal Cord Stimulator – Product Status 30

Spinal Cord Stimulator – Product Description 30

Hangzhou Shenluo Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Neuromodulation Device – Epilepsy – Product Status 31

Neuromodulation Device – Epilepsy – Product Description 31

Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 32

Wireless Intraspinal Microstimulation System – Product Status 32

Wireless Intraspinal Microstimulation System – Product Description 32

Lawson Health Research Institute Pipeline Products & Ongoing Clinical Trials Overview 33

Spinal Implant – Parkinson’s Disease – Product Status 33

Spinal Implant – Parkinson’s Disease – Product Description 33

Meagan Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 34

DISCSS IFC System – Product Status 34

DISCSS IFC System – Product Description 34

Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview 35

Inceptiv SCS – Product Status 35

Inceptiv SCS – Product Description 35

Medtronic Inc – Ongoing Clinical Trials Overview 36

Inceptiv SCS – Evaluation of Long-term Patient Experience with a Medtronic Closed-Loop Spinal Cord Stimulation System 37

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 38

Intellis – Painful Diabetic Neuropathy – Product Status 38

Intellis – Painful Diabetic Neuropathy – Product Description 38

Intellis – Upper Limb And Neck – Product Status 39

Intellis – Upper Limb And Neck – Product Description 39

Micro-Leads Inc Pipeline Products & Ongoing Clinical Trials Overview 40

HD64 Implantable Therapy System – Product Status 40

HD64 Implantable Therapy System – Product Description 40

Intelligent Spinal Interface – Product Status 41

Intelligent Spinal Interface – Product Description 41

MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview 42

SAINT System – Chronic Pain – Product Status 42

SAINT System – Chronic Pain – Product Description 42

Neuronoff Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Injectrode – Product Status 43

Injectrode – Product Description 43

Neuronoff Inc – Ongoing Clinical Trials Overview 44

Injectrode – Basic Assessment of Safety and Minimally Invasive Stimulation via Injectrode 45

NeuroOne Medical Technologies Corp Pipeline Products & Ongoing Clinical Trials Overview 46

Spinal Cord Stimulation System – Chronic Back Pain – Product Status 46

Spinal Cord Stimulation System – Chronic Back Pain – Product Description 46

Nevro Corp Pipeline Products & Ongoing Clinical Trials Overview 47

Omnia Upgrade – Product Status 48

Omnia Upgrade – Product Description 48

Senza HF10 Therapy System – Back Pain – Product Status 48

Senza HF10 Therapy System – Back Pain – Product Description 49

Senza HF10 Therapy System – Chronic Abdominal Pain – Product Status 49

Senza HF10 Therapy System – Chronic Abdominal Pain – Product Description 49

Senza HF10 Therapy System – Chronic Migraine – Product Status 50

Senza HF10 Therapy System – Chronic Migraine – Product Description 50

Senza HF10 Therapy System – Chronic Neck Pain – Product Status 50

Senza HF10 Therapy System – Chronic Neck Pain – Product Description 51

Senza HF10 Therapy System – CPSP – Product Status 51

Senza HF10 Therapy System – CPSP – Product Description 51

Senza HF10 Therapy System – Leg Pain – Product Status 52

Senza HF10 Therapy System – Leg Pain – Product Description 52

Senza HF10 Therapy System – Opioid Reduction – Product Status 52

Senza HF10 Therapy System – Opioid Reduction – Product Description 53

Senza HF10 Therapy System – Painful Diabetic Neuropathy – Product Status 53

Senza HF10 Therapy System – Painful Diabetic Neuropathy – Product Description 53

Senza HF10 Therapy System – Pelvic Pain – Product Status 54

Senza HF10 Therapy System – Pelvic Pain – Product Description 54

Senza HF10 Therapy System – Peripheral Polyneuropathy – Product Status 54

Senza HF10 Therapy System – Peripheral Polyneuropathy – Product Description 55

Senza HF10 Therapy System – Post-Surgical Pain – Product Status 55

Senza HF10 Therapy System – Post-Surgical Pain – Product Description 55

Senza HF10 Therapy System – Rescue Therapy – Product Status 56

Senza HF10 Therapy System – Rescue Therapy – Product Description 56

Senza HF10 Therapy System – Thoracic Pain – Product Status 56

Senza HF10 Therapy System – Thoracic Pain – Product Description 57

Senza HF10 Therapy System – Upper Extremity Pain – Product Status 57

Senza HF10 Therapy System – Upper Extremity Pain – Product Description 57

Senza HF10 Therapy System – Upper Limb Pain – Product Status 58

Senza HF10 Therapy System – Upper Limb Pain – Product Description 58

Senza HFX iQ Spinal Cord Stimulation System – Product Status 58

Senza HFX iQ Spinal Cord Stimulation System – Product Description 59

Nevro Corp – Ongoing Clinical Trials Overview 60

Senza HF10 Therapy System – Painful Diabetic Neuropathy – A Post-market, Multicenter, Prospective, Global Clinical Study to Evaluate the Real-world Experience of Spinal Cord Stimulation That Includes 10 kHz in the Management of Chronic Intractable Pain Associated with Diabetic Neuropathy 61

Senza HF10 Therapy System – Painful Diabetic Neuropathy – A Post-market, Multicenter, Prospective, Randomized Clinical Trial Comparing 10 kHz Spinal Cord Stimulation (HF10 Therapy) Combined with Conventional Medical Management to Conventional Medical Management Alone in the Treatment of Chronic, Intractable, Neuropathic Limb Pain 61

Senza HF10 Therapy System – Painful Diabetic Neuropathy – PDN-SENSORY: A Multi-Center Randomized Controlled Trial to Evaluate Pain and Neurological Function with 10 kHz SCS in Treatment of Painful Diabetic Neuropathy 61

Senza HF10 Therapy System – Back Pain – A Multi-center, Prospective, Pragmatic, Randomized, Controlled Clinical Trial to Compare HF10 Therapy to Conventional Medical Management in the Treatment of Non-surgical Refractory Back Pain 62

Senza HF10 Therapy System – Pelvic Pain – A Prospective Clinical Study to Assess the Spinal Cord Stimulation System in the Treatment of Chronic Pelvic Pain 63

Nexstim Plc Pipeline Products & Ongoing Clinical Trials Overview 64

Navigated Brain Therapy System – Chronic Spinal Cord Injury – Product Status 64

Navigated Brain Therapy System – Chronic Spinal Cord Injury – Product Description 64

Nuvectra Corp (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 65

Algovita SCS System – Full Body MRI – Product Status 65

Algovita SCS System – Full Body MRI – Product Description 65

Onward Medical NV Pipeline Products & Ongoing Clinical Trials Overview 66

Go-2 Targeted Epidural Spinal Stimulation Device – Product Status 66

Go-2 Targeted Epidural Spinal Stimulation Device – Product Description 66

Onward Medical NV – Ongoing Clinical Trials Overview 67

Go-2 Targeted Epidural Spinal Stimulation Device – Efficacy of Spinal Epidural Electrical Stimulation (EES) in Combination with Robot-assisted Neurorehabilitation in Patients with Spinal Cord Injury (STIMO) 68

Go-2 Targeted Epidural Spinal Stimulation Device – Targeting Improvements in Bowel Function and Quality of Life Using Epidural Stimulation and Training After Severe Spinal Cord Injury 68

Onward Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 69

ARC-BCI – Mobility – Product Status 69

ARC-BCI – Mobility – Product Description 70

ARC-BCI – Upper Limb – Product Status 70

ARC-BCI – Upper Limb – Product Description 70

ARC-BSI – Product Status 71

ARC-BSI – Product Description 71

ARC-EX – Product Status 71

ARC-EX – Product Description 72

ARC-EX – Bladder Control – Product Status 72

ARC-EX – Bladder Control – Product Description 72

ARC-EX – Mobility – Product Status 73

ARC-EX – Mobility – Product Description 73

ARC-EX – Sexual Function – Product Status 73

ARC-EX – Sexual Function – Product Description 74

ARC-IM – Blood Pressure And Trunk Control – Product Status 74

ARC-IM – Blood Pressure And Trunk Control – Product Description 74

ARC-IM – Parkinson’s Disease – Product Status 75

ARC-IM – Parkinson’s Disease – Product Description 75

ARCEX Neurostimulator – Product Status 75

ARCEX Neurostimulator – Product Description 76

Onward Technologies Ltd – Ongoing Clinical Trials Overview 77

ARC-EX – Activity Dependent Rehabilitation Via Transcutaneous Electrical Spinal Stimulation to Restore Upper Extremity Functions in Spinal Cord Injury 78

ARC-IM – Blood Pressure And Trunk Control – Epidural Electrical Stimulation to Restore Hemodynamic Stability and Trunk Control in People with Spinal Cord Injury 79

Quantum Nanostim LLC Pipeline Products & Ongoing Clinical Trials Overview 80

Clone System – Product Status 80

Clone System – Product Description 80

Reach Neuro Inc Pipeline Products & Ongoing Clinical Trials Overview 81

Avantis Device – Product Status 81

Avantis Device – Product Description 81

Rowan University Pipeline Products & Ongoing Clinical Trials Overview 82

Spinal Cord Stimulation Device – Chronic Pain – Product Status 82

Spinal Cord Stimulation Device – Chronic Pain – Product Description 82

Saluda Medical Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 83

Evoke Spinal Cord Stimulator System – Product Status 83

Evoke Spinal Cord Stimulator System – Product Description 83

Saluda Medical Pty Ltd – Ongoing Clinical Trials Overview 84

Evoke Spinal Cord Stimulator System – A Feasibility Study Evaluating Saluda Medical’s Spinal Cord Stimulation System Incorporating Feedback Control to Treat Patients with Chronic Pain of Upper Limb and/or Neck 85

Evoke Spinal Cord Stimulator System – A prospective Feasibility Study Examining the Ability of Closed-loop Spinal Cord Stimulation to Reduce Lower Limb Spasticity in Children Living with Cerebral Palsy: “The Liberty Trial” 85

Evoke Spinal Cord Stimulator System – A Prospective Study to Evaluate the Long-term Effectiveness, Safety, and Performance of the Saluda Medical’s Evoke Closed-Loop Spinal Cord Stimulation System to Treat Patients with Chronic Pain of the Trunk and/or Limbs 85

Evoke Spinal Cord Stimulator System – A Prospective, Multicentre, Single-arm Feasibility Study Examining Novel Treatment Delivery of the Evoke Spinal Cord Stimulator (SCS) System to Treat Patients with Chronic Pain of the Trunk And/or Limbs 86

Evoke Spinal Cord Stimulator System – EVOKE ECAP-Controlled Lead Placement and Programming in Chronic Pain Patients 86

Soin Neuroscience Inc Pipeline Products & Ongoing Clinical Trials Overview 87

Spinal Cord Stimulation System – Product Status 87

Spinal Cord Stimulation System – Product Description 87

Soterix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 88

1×1 tDCS Device – Product Status 88

1×1 tDCS Device – Product Description 89

tSDCS Cervical Strap – Product Status 89

tSDCS Cervical Strap – Product Description 89

tSDCS Lumbar BODYstrap – Product Status 90

tSDCS Lumbar BODYstrap – Product Description 90

tSDCS Shoulder Strap – Product Status 90

tSDCS Shoulder Strap – Product Description 91

Soterix Medical Inc – Ongoing Clinical Trials Overview 92

1×1 tDCS Device – Altering Multitasking Behavior Using Low Current Brain Stimulation 93

1×1 tDCS Device – Effects of tDCS on Post-stroke Fatigue and Inflammation 93

1×1 tDCS Device – Effects of Transcranial Direct Current Stimulation (tDCS) in Spoken and Written Production in Primary Progressive Aphasia (PPA) 93

1×1 tDCS Device – Effects of Transcranial Direct Current Stimulation (tDCS) on Motor Function in Schizophrenia Patients and Individuals at Risk for Psychotic Onset 94

1×1 tDCS Device – Impact of Neuromodulation on Language Impairments in Stroke Patients: A Multimodal Double-blind Randomized Controlled Study 94

1×1 tDCS Device – Non-invasive Neuromodulation to Enhance Targeted Cognitive Remediation in Older Adults With Depression 94

1×1 tDCS Device – Phase II Clinical Trial of Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia 95

1×1 tDCS Device – Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain with Machine Learning to Predict Treatment Response 95

1×1 tDCS Device – SMART Stimulation: Precision Neuromodulation of Cognition in Older Adults 95

1×1 tDCS Device – The Combined Effect of Robotic Rehabilitation and Transcranial Direct Current Stimulation on Proprioception in Chronic Stroke: a Pilot Study 96

1×1 tDCS Device – Tolerability of Transcranial Direct Current Stimulation in Pediatric Stroke Survivors 96

1×1 tDCS Device – Transcranial Direct Current Stimulation for Gait Recovery Following Stroke 96

1×1 tDCS Device – Using tDCS in Speech-based Stroke Rehabilitation 97

SpineX Pipeline Products & Ongoing Clinical Trials Overview 98

SCiP – Product Status 98

SCiP – Product Description 98

Scone Device – Product Status 99

Scone Device – Product Description 99

SpineX – Ongoing Clinical Trials Overview 100

Scone Device – Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals with Cerebral Palsy 101

Scone Device – The Effects of Transcutaneous Electrical Stimulation on Arm Functions in Individuals with Cervical Spinal Cord Injury 101

SCiP – Spinal Cord Innovation in Pediatrics (SCiP) to Treat SensoriMotor Function in Children Cerebral Palsy: Protocol for a Randomized Controlled Trial 102

SCiP – Transcutaneous Stimulation and Mobility Device Use for Individuals with Neurologic Conditions 102

Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 103

Spinal Cord Stimulator – Chronic Pain – Product Status 103

Spinal Cord Stimulator – Chronic Pain – Product Description 103

St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 104

Next Generation Implantable SCS System – Primary Cell – Product Status 104

Next Generation Implantable SCS System – Primary Cell – Product Description 104

Next Generation Implantable SCS System – Rechargeable – Product Status 105

Next Generation Implantable SCS System – Rechargeable – Product Description 105

Proclaim Rechargeable Model – Product Status 105

Proclaim Rechargeable Model – Product Description 105

Proclaim Upgrade HC – Product Status 106

Proclaim Upgrade HC – Product Description 106

Proclaim Upgrade LC – Product Status 106

Proclaim Upgrade LC – Product Description 107

Stimdia Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 108

pdSTIM System – Product Status 108

pdSTIM System – Product Description 108

SynerFuse Inc Pipeline Products & Ongoing Clinical Trials Overview 109

NeuroFuse DRG System – Product Status 109

NeuroFuse DRG System – Product Description 109

SynerFuse Inc – Ongoing Clinical Trials Overview 110

NeuroFuse DRG System – Pilot Trial to Investigate NeuroFuse DRG Therapy in Patients with Chronic Lower Back Pain 111

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 112

32-Electrode Neurostimulator – Product Status 112

32-Electrode Neurostimulator – Product Description 112

Spinal Cord Electrical Stimulator – Product Status 113

Spinal Cord Electrical Stimulator – Product Description 113

University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 114

Inflatable Spinal Implant – Product Status 114

Inflatable Spinal Implant – Product Description 114

University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 115

Spinal Cord Stimulation Device – Product Status 115

Spinal Cord Stimulation Device – Product Description 115

University of Minnesota – Ongoing Clinical Trials Overview 116

Spinal Cord Stimulation Device – Epidural Stimulation for Spinal Cord Injury 117

Wavegate Corp Pipeline Products & Ongoing Clinical Trials Overview 118

StimuLux – Product Status 118

StimuLux – Product Description 118

WISE s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 119

SCS EXPERT – Product Status 119

SCS EXPERT – Product Description 119

Glossary 146

Figures

Spinal Cord Stimulators (SCS) – Pipeline Products by Stage of Development 12

Spinal Cord Stimulators (SCS) – Pipeline Products by Territory 13

Spinal Cord Stimulators (SCS) – Pipeline Products by Regulatory Path 14

Spinal Cord Stimulators (SCS) – Pipeline Products by Estimated Approval Date 15

Spinal Cord Stimulators (SCS) – Ongoing Clinical Trials 16

Frequently asked questions

Spinal Cord Stimulators (SCS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Spinal Cord Stimulators (SCS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Spinal Cord Stimulators (SCS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Spinal Cord Stimulators (SCS) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.